Skip to Main Content

Advertisement

Skip Nav Destination

FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

Clin Cancer Res (2024) 30 (1): 17–22.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Qian Wang
  • Yeping Bian
  • Gagan Dhawan
  • Wei Zhang
  • Alexander E. Sorochinsky
  • Ata Makarem
  • Vadim A. Soloshonok
  • Jianlin Han
Chinese Chemical Letters 109780.
  • Haotian Wang
  • Xin Wan
  • Ying Zhang
  • Jing Guo
  • Ou Bai
Frontiers in Oncology (2024) 14
Close Modal

or Create an Account

Close Modal
Close Modal